期刊文献+

载脂蛋白E(apoE)和脂蛋白脂酶(LPL)双基因敲除小鼠(apoE^-/-/LPL^+/-)用于大豆异黄酮调血脂作用研究 被引量:2

Research on Blood Lipid Regulating Effects of Soybean Isoflavones by Both apoE and LPL Gene Deficient (apoE^-/-/LPL^+/-) Mice
下载PDF
导出
摘要 目的探讨大豆异黄酮提取物对高胆固醇合并高甘油三酯血症基因工程小鼠的调血脂作用。方法高脂饮食条件下,以C57BL/6成年小鼠10只(65,早5)为正常对照,载脂蛋白E和脂蛋白脂酶双基因缺陷(apoE^-/-/LPL^+/-)成年小鼠(ELK小鼠)40只(620,早20),随机分为4组:高脂模型组,每天200mg/kg大豆异黄酮提取物,每周阳性对照药0.5mg/kg尼尔雌醇和每天20mg/kg洛伐他汀灌胃组。连续灌胃给药4周,测定血清总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和血糖含量。结果与C57BL/6空白对照组相比,ELK高脂模型组小鼠的血清TC、TG和LDL—c含量均极显著增高(P〈0.01)。与高脂模型组相比,大豆异黄酮给药4周可显著降低ELK小鼠血清TG含量(P〈0.05),同时使血清HDL—c增加9.3%,而洛伐他汀和尼尔雌醇组分别降低了13.5%和8.7%;高脂诱导的ELK小鼠血清TC、LDL—c水平极度增高,大豆异黄酮、洛伐他汀和尼尔雌醇均不能显著降低TC、LDL-c含量(P〉0.05)。结论大豆异黄酮有明显调血脂作用。 Objective To investigate the lipid regulating effects of soybean isoflavone extracts on genetic engineering mice with both hypercholesterolemia and hypertriglyceridemia. Method Under the western-type food conditioning, 10 ( ♂ 5, ♀ 5) adult C57BL/6 mice were used as control, 40 adult mice with both aopE and LPL gene deficiency (apoE^-/-/LPL^+/-) were divided into four groups, i.e., the group of animal models of hyperlipidemia, three groups of intragastric administration respectively with dose of 200 mg·kg^-1·d^-1 of soybean isoflavone extracts, 0.5 mg·kg^-1 of nylestrodial per week and 20 mg·kg^-1·d^-1 of lovastatin. After four weeks consecutive administration, concentration of serum total cholesterol, triacylglycerol, HDL cholesterol, LDL cholesterol and glucose were determined. Result Compared with the control mice of C57BL/6, the diet induced models of hyperlipidemia had a remarkable increase in triglyceride, total and LDL cholesterol (P〈0.01). Compared with models of hyperlipidemia, administration of soybean isoflavones had a favorable reduction in triglyceride (P〈0.05) and a 9.3% increase in HDL cholesterol, while administration of nylestrodial and lovastatin had 13.5% and 8.7% reduction in HDL cholesterol respectively. Probably due to the greatly increased total and LDL cholesterol in apoE^-/-/LPL^+/- mice, there is no effects of soybean isoflavone, nylestrodial and lovastatin on both the variables. Conclusion Soybean isoflavones had evident favorable lipid regulating effects.
出处 《实验动物与比较医学》 CAS 2009年第1期12-16,共5页 Laboratory Animal and Comparative Medicine
关键词 大豆异黄酮 APOE基因 LPL基因 基因敲除 apoE和LPL双基因缺陷(apoE^-/-/LPL^+/-)小鼠 血脂 Soybean isoflavones apoE gene LPL gene Gene knockout apoE and LPL gene deficient (apoE^-/-/LPL^+/-) mice Blood lipid
  • 相关文献

参考文献22

  • 1Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: potential mechanisms [J]. Am J Clin Nutr, 1998, 68: 1390S-1393S.
  • 2Barnes S. Soy isoflavones: phytoestrogens and what else [J]? J Nutr, 2004, 134: 1225S-1228S.
  • 3Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens [J]. J Clin Endocrinol Metab, 2001, 86:41- 47.
  • 4Lichtenstein AH, Jalbert SM, Adlercreutz H, et al. Rasmussen Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholester- olemic subjects [J]. Arterioscler Thromb Vasc Biol, 2002, 22: 1852-1858.
  • 5Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial [J]. JAMA, 2004, 292:65-74.
  • 6Weggemans RM, Trautwein EA. Relation between soy-asso- ciated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis [J]. Eur J Clin Nutr, 2003, 57:940-946.
  • 7Squadrito F, Altavilla D, Morabito N, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium depen-dent vasodilation in postmenopausal women [J]. Atherosclerosis, 2002, 163:339-347.
  • 8Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies [J]. Am J Clin Nutr, 2003, 78:593S-609S.
  • 9Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer [J]. Br J Nutr, 2004, 91: 513-531.
  • 10Harris WS. N-3 fatty acids and serum lipoproteins :animal studies [J]. Am J Clin Nutr. 1997, 65: 1161-1166.

二级参考文献50

  • 1周淑佩,张晓红,刘国庆,田枫.混合性高甘油三酯/高胆固醇血症小鼠模型的培育[J].中国比较医学杂志,2005,15(6):368-371. 被引量:3
  • 2孙东风,诸骏仁,宋后燕.动脉粥样硬化性疾病患者血浆纤溶活性的变化及与血脂的关系[J].中国动脉硬化杂志,1996,4(4):264-267. 被引量:4
  • 3张林华 刘秉文 等.高糖膳食对血浆胰岛素、cAMP含量及cAMP组织代谢的影响[J].生物化学杂志,1986,2:19-25.
  • 4Miller M, Cosgrove B, Havas S. Update on the role of triglycerides as a risk factor for coronary heart disease[J].Curr Atheroscler Rep, 2002, 4(6) :414 - 418.
  • 5Instull W Jr, Toth P, Mullican W, et al. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial[ J ]. Mayo Clin Proc, 2001, 76(10) :971 - 982.
  • 6Weston C. The place of ezetimibe in clinical practice[J].Hosp Med, 2003, 64(8) :473 -478.
  • 7Kerzner B, Corbelli J, Sharp S, et al. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia[J]. Am J Cardiol, 2003, 91 (4):418 -424.
  • 8Stein EA. An investigative look: selective cholesterol absorption inhibitors - embarking on a new standard of care[J]. Am L Manag Care, 2002, 8(2 Suppl):S36 - S39.
  • 9Olsson AG, Istad H, Luurila O, et al. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia[ J]. Am Heart J, 2002,144(6): 1044 - 1051.
  • 10Martin PD, Mitchell PD, Schneck DW. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers[ J]. Br J Clin Pharmacol, 2002,54(5) :472 - 477.

共引文献85

同被引文献35

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部